Trends in developing one-pot CRISPR diagnostics strategies

Trends Biotechnol. 2024 Aug 1:S0167-7799(24)00185-9. doi: 10.1016/j.tibtech.2024.07.007. Online ahead of print.

Abstract

The integration of nucleic acid amplification (NAA) with the CRISPR detection system has led to significant advancements and opportunities for development in molecular diagnostics. Nevertheless, the incompatibility between CRISPR cleavage and NAA has significantly impeded the commercialization of this technology. Currently, several one-pot detection strategies based on CRISPR systems have been devised to address concerns regarding aerosol contamination risk and operational complexity associated with step-by-step detection as well as the sensitivity limitation of conventional one-pot methods. In this review, we provide a comprehensive introduction and outlook of the various solutions of the one-pot CRISPR assay for practitioners who are committed to developing better CRISPR nucleic acid detection technologies to promote the progress of molecular diagnostics.

Keywords: CRISPR–Cas system; nucleic acid amplification; nucleic acid detection; one-pot assay.

Publication types

  • Review